Bacterial toxins that modulate host cell-cycle progression.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 15694861)

Published in Curr Opin Microbiol on February 01, 2005

Authors

Eric Oswald1, Jean-Philippe Nougayrède, Frédéric Taieb, Motoyuki Sugai

Author Affiliations

1: UMR1225 "Interactions Hôtes-Agents Pathogènes", Ecole Nationale Vétérinaire, 23 chemin des Capelles, 31076 Toulouse, France. e.oswald@envt.fr

Articles citing this

Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun (2009) 1.93

Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology (2011) 1.40

Mycobacterium tuberculosis arrests host cycle at the G1/S transition to establish long term infection. PLoS Pathog (2017) 1.38

Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res (2008) 1.29

A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle. Proc Natl Acad Sci U S A (2009) 1.29

P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect (2007) 1.23

Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog (2010) 1.23

Photorhabdus luminescens genes induced upon insect infection. BMC Genomics (2008) 1.22

Pasteurella multocida: from zoonosis to cellular microbiology. Clin Microbiol Rev (2013) 1.21

Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J Mol Biol (2008) 1.16

Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun (2006) 1.16

Infection with Toxoplasma gondii results in dysregulation of the host cell cycle. Cell Microbiol (2008) 1.14

Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One (2009) 1.08

The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth. Nature (2008) 1.07

Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07

Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida. FEBS J (2011) 1.06

Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J Biol Chem (2010) 1.06

Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Mol Microbiol (2005) 1.05

Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer. Am J Pathol (2009) 1.04

Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect Immun (2008) 1.02

A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage. PLoS One (2008) 1.00

Gut microbiota imbalance and colorectal cancer. World J Gastroenterol (2016) 0.99

The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect Immun (2009) 0.95

Role of intrachain disulfides in the activities of the CdtA and CdtC subunits of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Infect Immun (2006) 0.93

Localization of Aggregatibacter actinomycetemcomitans cytolethal distending toxin subunits during intoxication of live cells. Infect Immun (2012) 0.91

Cyclomodulins in urosepsis strains of Escherichia coli. J Clin Microbiol (2010) 0.90

Functional and structural characterization of chimeras of a bacterial genotoxin and human type I DNAse. FEMS Microbiol Lett (2008) 0.89

Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol (2010) 0.88

Differential gene expression profiling of porcine epithelial cells infected with three enterotoxigenic Escherichia coli strains. BMC Genomics (2012) 0.88

Epithelial cell proliferation arrest induced by lactate and acetate from Lactobacillus casei and Bifidobacterium breve. PLoS One (2013) 0.86

Genome-wide analysis of cellular response to bacterial genotoxin CdtB in yeast. Infect Immun (2007) 0.86

Laser microdissection coupled with RNA-seq analysis of porcine enterocytes infected with an obligate intracellular pathogen (Lawsonia intracellularis). BMC Genomics (2013) 0.86

Enteric pathogens deploy cell cycle inhibiting factors to block the bactericidal activity of Perforin-2. Elife (2015) 0.86

Cycle inhibiting factors (cifs): cyclomodulins that usurp the ubiquitin-dependent degradation pathway of host cells. Toxins (Basel) (2011) 0.86

Cellular interactions of the cytolethal distending toxins from Escherichia coli and Haemophilus ducreyi. J Biol Chem (2013) 0.84

Escherichia coli cytotoxic necrotizing factor 1 blocks cell cycle G2/M transition in uroepithelial cells. Infect Immun (2006) 0.84

The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators. Toxins (Basel) (2013) 0.83

Deep sequencing-based transcriptional analysis of bovine mammary epithelial cells gene expression in response to in vitro infection with Staphylococcus aureus stains. PLoS One (2013) 0.83

Breaking the Gingival Epithelial Barrier: Role of the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin in Oral Infectious Disease. Cells (2014) 0.83

Nonstructural protein σ1s mediates reovirus-induced cell cycle arrest and apoptosis. J Virol (2013) 0.80

Signaling cascades of Pasteurella multocida toxin in immune evasion. Toxins (Basel) (2013) 0.79

Male killing Spiroplasma preferentially disrupts neural development in the Drosophila melanogaster embryo. PLoS One (2013) 0.79

Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges. Clin Microbiol Rev (2014) 0.79

Human genome-wide RNAi screen for host factors that modulate intracellular Salmonella growth. PLoS One (2012) 0.79

Reduced set of virulence genes allows high accuracy prediction of bacterial pathogenicity in humans. PLoS One (2012) 0.79

Rho/ROCK-dependent inhibition of 3T3-L1 adipogenesis by G-protein-deamidating dermonecrotic toxins: differential regulation of Notch1, Pref1/Dlk1, and β-catenin signaling. Front Cell Infect Microbiol (2012) 0.78

Listeria monocytogenes induces host DNA damage and delays the host cell cycle to promote infection. Cell Cycle (2014) 0.78

Evolution of a self-inducible cytolethal distending toxin type V-encoding bacteriophage from Escherichia coli O157:H7 to Shigella sonnei. J Virol (2013) 0.78

Impact of CDT Toxin on Human Diseases. Toxins (Basel) (2016) 0.78

Single nucleotide polymorphism in the cytolethal distending toxin B gene confers heterogeneity in the cytotoxicity of Actinobacillus actinomycetemcomitans. Infect Immun (2006) 0.77

Sequence variability of P2-like prophage genomes carrying the cytolethal distending toxin V operon in Escherichia coli O157. Appl Environ Microbiol (2013) 0.76

In vitro alterations do not reflect a requirement for host cell cycle progression during Plasmodium liver stage infection. Eukaryot Cell (2014) 0.75

Staphylococcus aureus Lpl Lipoproteins Delay G2/M Phase Transition in HeLa Cells. Front Cell Infect Microbiol (2016) 0.75

Cytolethal Distending Toxin From Campylobacter jejuni Requires the Cytoskeleton for Toxic Activity. Jundishapur J Microbiol (2016) 0.75

Legionella pneumophila prevents proliferation of its natural host Acanthamoeba castellanii. Sci Rep (2016) 0.75

Disease and Carrier Isolates of Neisseria meningitidis Cause G1 Cell Cycle Arrest in Human Epithelial Cells. Infect Immun (2016) 0.75

Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections. Front Cell Infect Microbiol (2017) 0.75

Articles by these authors

Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science (2006) 4.58

A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol (2010) 3.20

Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A (2010) 3.18

Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob Agents Chemother (2004) 2.15

Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol (2003) 1.96

Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun (2009) 1.93

Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun (2003) 1.90

Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect Immun (2002) 1.89

Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol (2005) 1.87

Identification and molecular characterization of an N-acetylmuramyl-L-alanine amidase Sle1 involved in cell separation of Staphylococcus aureus. Mol Microbiol (2005) 1.72

Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol (2005) 1.66

Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest (2002) 1.64

Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis (2007) 1.61

Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima. J Antimicrob Chemother (2009) 1.56

The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol (2009) 1.51

Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother (2005) 1.50

Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges. J Biol Chem (2005) 1.48

The gate controlling cell wall synthesis in Staphylococcus aureus. Mol Microbiol (2004) 1.47

Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6. Diagn Microbiol Infect Dis (2011) 1.43

Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci (2007) 1.37

Extensive genomic diversity and selective conservation of virulence-determinants in enterohemorrhagic Escherichia coli strains of O157 and non-O157 serotypes. Genome Biol (2007) 1.37

Molecular characterization of an atl null mutant of Staphylococcus aureus. Microbiol Immunol (2002) 1.35

Staphylococcus aureus MazF specifically cleaves a pentad sequence, UACAU, which is unusually abundant in the mRNA for pathogenic adhesive factor SraP. J Bacteriol (2009) 1.31

Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog (2010) 1.23

Outer membrane protein 100, a versatile virulence factor of Actinobacillus actinomycetemcomitans. Mol Microbiol (2003) 1.23

Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis (2002) 1.20

Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems. J Clin Microbiol (2013) 1.19

Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27. Cell Microbiol (2008) 1.18

Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA-damage checkpoint-signalling pathway. Cell Microbiol (2006) 1.18

Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J Mol Biol (2008) 1.16

An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem (2003) 1.14

Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. J Invest Dermatol (2002) 1.13

Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J Antimicrob Chemother (2008) 1.11

Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins. J Clin Microbiol (2005) 1.11

Increased glycan chain length distribution and decreased susceptibility to moenomycin in a vancomycin-resistant Staphylococcus aureus mutant. Antimicrob Agents Chemother (2002) 1.10

Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes (2012) 1.09

Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One (2009) 1.08

Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge. Microbes Infect (2003) 1.07

ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J Biol Chem (2011) 1.07

Identification of six major outer membrane proteins from Actinobacillus actinomycetemcomitans. Gene (2002) 1.05

Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J Clin Microbiol (2003) 1.03

Caspase-2 and caspase-7 are involved in cytolethal distending toxin-induced apoptosis in Jurkat and MOLT-4 T-cell lines. Infect Immun (2004) 1.03

Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect Immun (2008) 1.02

Cytolethal distending toxin: a bacterial bullet targeted to nucleus. J Biochem (2004) 1.01

Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS One (2013) 1.00

Staphylococcus hyicus exfoliative toxins selectively digest porcine desmoglein 1. Microb Pathog (2005) 1.00

A simple method of markerless gene deletion in Staphylococcus aureus. J Microbiol Methods (2011) 0.98

New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of beta-defensins, LL37, and TLR2. Eur J Immunol (2005) 0.97

Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice. J Dermatol Sci (2013) 0.97

The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect Immun (2009) 0.95

Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in Staphylococcus aureus. Microbiol Immunol (2003) 0.95

Interplay between siderophores and colibactin genotoxin biosynthetic pathways in Escherichia coli. PLoS Pathog (2013) 0.94

FtsZ-dependent localization of GroEL protein at possible division sites. Genes Cells (2004) 0.94

A novel metallo-β-lactamase, IMP-34, in Klebsiella isolates with decreased resistance to imipenem. Diagn Microbiol Infect Dis (2013) 0.94

Innate defences against methicillin-resistant Staphylococcus aureus (MRSA) infection. J Pathol (2006) 0.94

Expression of virulence factors by Staphylococcus aureus grown in serum. Appl Environ Microbiol (2011) 0.93

In vitro evolution of an archetypal enteropathogenic Escherichia coli strain. J Bacteriol (2013) 0.92

Distinct two-component systems in methicillin-resistant Staphylococcus aureus can change the susceptibility to antimicrobial agents. J Antimicrob Chemother (2010) 0.91

Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue. Microbiology (2009) 0.90

Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin. Infect Immun (2006) 0.90

CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes. Int Immunol (2007) 0.89

Actinobacillus actinomycetemcomitans outer membrane protein 100 triggers innate immunity and production of beta-defensin and the 18-kilodalton cationic antimicrobial protein through the fibronectin-integrin pathway in human gingival epithelial cells. Infect Immun (2006) 0.89

First isolation of blaIMP-7 in a Pseudomonas aeruginosa in Japan. J Infect Chemother (2007) 0.87

Cloning of swine desmoglein 1 and its direct proteolysis by Staphylococcus hyicus exfoliative toxins isolated from pigs with exudative epidermitis. Vet Dermatol (2005) 0.87

Cytolethal distending toxin from Aggregatibacter actinomycetemcomitans induces DNA damage, S/G2 cell cycle arrest, and caspase- independent death in a Saccharomyces cerevisiae model. Infect Immun (2009) 0.87

Bacitracin sensing and resistance in Staphylococcus aureus. FEMS Microbiol Lett (2011) 0.87

Mutation analysis of the histidine residues in the glycylglycine endopeptidase ALE-1. J Bacteriol (2005) 0.87

The Listeria monocytogenes serotype 4b autolysin IspC has N-acetylglucosaminidase activity. Glycobiology (2012) 0.87

Tripoli metallo-β-lactamase-1 (TMB-1)-producing Acinetobacter spp. with decreased resistance to imipenem in Japan. Antimicrob Agents Chemother (2014) 0.86

The molecular basis of ubiquitin-like protein NEDD8 deamidation by the bacterial effector protein Cif. Proc Natl Acad Sci U S A (2012) 0.86

Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases. Curr Pharm Des (2007) 0.86

Cycle inhibiting factors (cifs): cyclomodulins that usurp the ubiquitin-dependent degradation pathway of host cells. Toxins (Basel) (2011) 0.86

Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage phiEF24C. Appl Environ Microbiol (2010) 0.85

Cif type III effector protein: a smart hijacker of the host cell cycle. Future Microbiol (2009) 0.85

Zymographic characterization of bacteriolytic enzymes produced by oral streptococci. Microbiol Immunol (2004) 0.85

Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. J Gastroenterol (2013) 0.85

Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus. Microbiology (2011) 0.85

Cytolethal distending toxin induces caspase-dependent and -independent cell death in MOLT-4 cells. Infect Immun (2008) 0.85

Identification and characterization of a novel aac(6')-Iag associated with the blaIMP-1-integron in a multidrug-resistant Pseudomonas aeruginosa. PLoS One (2013) 0.84

The carbon storage regulator (Csr) system exerts a nutrient-specific control over central metabolism in Escherichia coli strain Nissle 1917. PLoS One (2013) 0.84

Macrophage inflammatory protein-3alpha and beta-defensin-2 stimulate dentin sialophosphoprotein gene expression in human pulp cells. Biochem Biophys Res Commun (2003) 0.84

Epidemiology, variable genetic organization and regulation of the EDIN-B toxin in Staphylococcus aureus from bacteraemic patients. Microbiology (2009) 0.82

Staphylococcus aureus-induced G2/M phase transition delay in host epithelial cells increases bacterial infective efficiency. PLoS One (2013) 0.82

Identification of a novel Staphylococcus pseudintermedius exfoliative toxin gene and its prevalence in isolates from canines with pyoderma and healthy dogs. FEMS Microbiol Lett (2010) 0.82

Regulatory mechanism for exfoliative toxin production in Staphylococcus aureus. Infect Immun (2011) 0.82

Irsogladine maleate influences the response of gap junctional intercellular communication and IL-8 of human gingival epithelial cells following periodontopathogenic bacterial challenge. Biochem Biophys Res Commun (2005) 0.82

Molecular characterization of imipenem-resistant Pseudomonas aeruginosa in Hiroshima, Japan. Microbiol Immunol (2007) 0.82

Structural insight into the binding mode between the targeting domain of ALE-1 (92AA) and pentaglycine of peptidoglycan. Protein Eng Des Sel (2009) 0.81

Syntheses of prostaglandin E2 and E-cadherin and gene expression of beta-defensin-2 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans. Inflammation (2003) 0.80

Identification and molecular characterization of an N-Acetylmuraminidase, Aml, involved in Streptococcus mutans cell separation. Microbiol Immunol (2006) 0.80

Bacteriocin protein BacL1 of Enterococcus faecalis is a peptidoglycan D-isoglutamyl-L-lysine endopeptidase. J Biol Chem (2013) 0.80

Rapid detection of blaIMP-6 by amplification refractory mutation system. J Microbiol Methods (2011) 0.79